chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Product dose omission issue
Clinical narrative: Patient did not receive second Moderna Covid-19 vaccine greater than 35 days.; Palpitation; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitation) and PRODUCT DOSE OMISSION ISSUE (Patient did not receive second Moderna Covid-19 vaccine greater than 35 days.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included High cholesterol, Palpitations (for 4 years, 2-3 times per year) and White blood cell count low.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PALPITATIONS (Palpitation). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive second Moderna Covid-19 vaccine greater than 35 days.). At the time of the report, PALPITATIONS (Palpitation) and PRODUCT DOSE OMISSION ISSUE (Patient did not receive second Moderna Covid-19 vaccine greater than 35 days.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-124288, US-MODERNATX, INC.-MOD-2021-124831 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up information was received on 12 May 2021 wherein reporter contact details were updated and event was added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-124831: US-MODERNATX, INC.-MOD-2021-124288:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Vomiting
Clinical narrative: Nausea; Sore arm; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), NAUSEA (Nausea) and VOMITING (Vomiting) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.  Concomitant products included LABETALOL, LISINOPRIL, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE and SIMVASTATIN for an unknown indication.  On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 15-Mar-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) for Symptomatic treatment, at an unspecified dose and frequency. On 13-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 18-Mar-2021, NAUSEA (Nausea) and VOMITING (Vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Pain, Pyrexia
Clinical narrative: Severe pain in armpits; Had soreness; Fatigue; Felt feverish; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Severe pain in armpits), PAIN (Had soreness), FATIGUE (Fatigue) and PYREXIA (Felt feverish) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced AXILLARY PAIN (Severe pain in armpits), PAIN (Had soreness), FATIGUE (Fatigue) and PYREXIA (Felt feverish). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown and VITAMIN D NOS at a dose of unknown. At the time of the report, AXILLARY PAIN (Severe pain in armpits) and PYREXIA (Felt feverish) had not resolved and PAIN (Had soreness) and FATIGUE (Fatigue) was resolving.            No concomitant medications were reported.  Treatment of the events included, paracetamol, vitamin D and lots of water.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: COVID19 arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (COVID19 arm) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history was reported.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (COVID19 arm). The patient was treated with TRIAMCINOLONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (COVID19 arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details included cold packs to arm.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site swelling
Clinical narrative: fatigue; real tired; swelling at the injection site - left arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), FATIGUE (real tired) and INJECTION SITE SWELLING (swelling at the injection site - left arm) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for an unknown indication.     The patient's past medical history included No adverse reaction.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced FATIGUE (fatigue), FATIGUE (real tired) and INJECTION SITE SWELLING (swelling at the injection site - left arm). At the time of the report, FATIGUE (fatigue), FATIGUE (real tired) and INJECTION SITE SWELLING (swelling at the injection site - left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain
Clinical narrative: Cough started 2 days before vaccination but now more in her a day after vaccination, it got worse; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough started 2 days before vaccination but now more in her a day after vaccination, it got worse) and OROPHARYNGEAL PAIN (Sore throat) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.  The patient's past medical history included Cough since an unknown date.  On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced COUGH (Cough started 2 days before vaccination but now more in her a day after vaccination, it got worse) and OROPHARYNGEAL PAIN (Sore throat). The patient was treated with SILVER (COLLOIDAL SILVER) for Cough, at an unspecified dose and frequency. At the time of the report, COUGH (Cough started 2 days before vaccination but now more in her a day after vaccination, it got worse) and OROPHARYNGEAL PAIN (Sore throat) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: tongue is numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (tongue is numb) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included no adverse drug effect.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (tongue is numb). At the time of the report, HYPOAESTHESIA ORAL (tongue is numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelling under the injection arm after receiving the 1st dose of Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (swelling under the injection arm after receiving the 1st dose of Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy since an unknown date.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling under the injection arm after receiving the 1st dose of Moderna vaccine). At the time of the report, VACCINATION SITE SWELLING (swelling under the injection arm after receiving the 1st dose of Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications taken by the patient were not provided. Treatment information was not provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: rash at injection site; red at the injection site; very warm to touch; itching at the injection site; redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site), VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE WARMTH (very warm to touch), VACCINATION SITE PRURITUS (itching at the injection site) and ERYTHEMA (redness) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016N20A - 016M20A (not sure) and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included Diabetes. Concomitant products included OMEPRAZOLE for Antacid therapy, METFORMIN and SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) for Diabetes, NAPROXEN, LISINOPRIL, PRAVASTATIN and MULTIVITAMIN & MINERAL for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (redness) and PRURITUS (itching). On 13-Mar-2021, the patient experienced VACCINATION SITE RASH (rash at injection site), VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE WARMTH (very warm to touch) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE RASH (rash at injection site), VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE WARMTH (very warm to touch), VACCINATION SITE PRURITUS (itching at the injection site), ERYTHEMA (redness) and PRURITUS (itching) had not resolved. Not Provided
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: rash at injection site; red at the injection site; very warm to touch; itching at the injection site; redness; itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site), VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE WARMTH (very warm to touch), VACCINATION SITE PRURITUS (itching at the injection site) and ERYTHEMA (redness) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016N20A - 016M20A (not sure) and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included Diabetes. Concomitant products included OMEPRAZOLE for Antacid therapy, METFORMIN and SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) for Diabetes, NAPROXEN, LISINOPRIL, PRAVASTATIN and MULTIVITAMIN & MINERAL for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (redness) and PRURITUS (itching). On 13-Mar-2021, the patient experienced VACCINATION SITE RASH (rash at injection site), VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE WARMTH (very warm to touch) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE RASH (rash at injection site), VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE WARMTH (very warm to touch), VACCINATION SITE PRURITUS (itching at the injection site), ERYTHEMA (redness) and PRURITUS (itching) had not resolved. Not Provided
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Pain in extremity
Clinical narrative: Pain in neck after 2nd dose; Pain in arm after 2nd dose; Pain in shoulder after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN, PAIN IN EXTREMITY, and ARTHRALGIA in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN, PAIN IN EXTREMITY, and ARTHRALGIA. At the time of the report, NECK PAIN, PAIN IN EXTREMITY, and ARTHRALGIA outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot to the touch Injection Site; Swollen Injection Site; Red about 4" Injection Site; Itching Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to the touch Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE ERYTHEMA (Red about 4" Injection Site) and VACCINATION SITE PRURITUS (Itching Injection Site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE ERYTHEMA (Red about 4" Injection Site) and VACCINATION SITE PRURITUS (Itching Injection Site). At the time of the report, VACCINATION SITE WARMTH (Hot to the touch Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE ERYTHEMA (Red about 4" Injection Site) and VACCINATION SITE PRURITUS (Itching Injection Site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: rapid and PCR came back positive (for Covid-19); This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (rapid and PCR came back positive (for Covid-19)) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced COVID-19 (rapid and PCR came back positive (for Covid-19)). On 23-Mar-2021, COVID-19 (rapid and PCR came back positive (for Covid-19)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, SARS-CoV-2 test: positive (Positive) COVID-19 rapid test. On 10-Mar-2021, SARS-CoV-2 test: positive (Positive) PCR COVID-19 test.         Patient had chills. It was reported that consumer was quarantined from 08 Mar 2021 until 23 Mar 2021. The symptoms have resolved but the consumer had not been retested for COVID-19.  No concomitant medication was reported  No treatment medication was reported   This case was linked to US-MODERNATX, INC.-MOD-2021-118325 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Reporter details were updated. Second dose information updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-118325:Case for second dose
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Rash erythematous
Clinical narrative: "red rash over the body that spreading"; nausea; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS ("red rash over the body that spreading") and NAUSEA (nausea) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included CLONIDINE and METHADONE HYDROCHLORIDE (DOLOPHINE) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced RASH ERYTHEMATOUS ("red rash over the body that spreading") and NAUSEA (nausea). At the time of the report, RASH ERYTHEMATOUS ("red rash over the body that spreading") and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: nausea; strong headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and HEADACHE (strong headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced NAUSEA (nausea) and HEADACHE (strong headache). At the time of the report, NAUSEA (nausea) and HEADACHE (strong headache) outcome was unknown. Not Provided
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Pain, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body aches) and CHILLS (Chills) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PAIN (Body aches) and CHILLS (Chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), PAIN (Body aches) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Patient was pre-medicated with Tylenol and Benadryl two hours prior to vaccine and took again 6 hours after the vaccine.   This case was linked to MOD21-061231, MOD-2021-056044 (E2B Linked Report). This case was linked to MOD-2021-056031 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up was received contains no new information; Sender's Comments:  MOD21-061231: MOD-2021-056044:Wife's Case
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Eye pain, Feeling abnormal, Headache, Neck pain
Clinical narrative: sore arm; pain moved to the back of the neck; headache; terrible toothache; ear pain; eye pain; pain was mostly left side; whole body felt terrible; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NECK PAIN (pain moved to the back of the neck), HEADACHE (headache), TOOTHACHE (terrible toothache) and EAR PAIN (ear pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029az1a and 016bz1a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No reported medical history. and concomitant drugs are provided.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), NECK PAIN (pain moved to the back of the neck), HEADACHE (headache), TOOTHACHE (terrible toothache), EAR PAIN (ear pain), EYE PAIN (eye pain), PAIN (pain was mostly left side) and FEELING ABNORMAL (whole body felt terrible). At the time of the report, PAIN IN EXTREMITY (sore arm), HEADACHE (headache), TOOTHACHE (terrible toothache), EAR PAIN (ear pain), EYE PAIN (eye pain), PAIN (pain was mostly left side) and FEELING ABNORMAL (whole body felt terrible) had resolved and NECK PAIN (pain moved to the back of the neck) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  Treatment information was not provided. Lab details were not provided.   This case was linked to MOD-2021-121822 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11-MAY-2021 Outcome of the events added. 2 nd dose information added. Concomitant product added. Patient demographics added(Height, Weight, Race)
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Toothache
Clinical narrative: sore arm; pain moved to the back of the neck; headache; terrible toothache; ear pain; eye pain; pain was mostly left side; whole body felt terrible; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NECK PAIN (pain moved to the back of the neck), HEADACHE (headache), TOOTHACHE (terrible toothache) and EAR PAIN (ear pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029az1a and 016bz1a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No reported medical history. and concomitant drugs are provided.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), NECK PAIN (pain moved to the back of the neck), HEADACHE (headache), TOOTHACHE (terrible toothache), EAR PAIN (ear pain), EYE PAIN (eye pain), PAIN (pain was mostly left side) and FEELING ABNORMAL (whole body felt terrible). At the time of the report, PAIN IN EXTREMITY (sore arm), HEADACHE (headache), TOOTHACHE (terrible toothache), EAR PAIN (ear pain), EYE PAIN (eye pain), PAIN (pain was mostly left side) and FEELING ABNORMAL (whole body felt terrible) had resolved and NECK PAIN (pain moved to the back of the neck) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  Treatment information was not provided. Lab details were not provided.   This case was linked to MOD-2021-121822 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11-MAY-2021 Outcome of the events added. 2 nd dose information added. Concomitant product added. Patient demographics added(Height, Weight, Race)
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia, Pruritus, Rash erythematous
Clinical narrative: Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash; Arm itchy/not as itchy as after her first dose; feel a slight tingling in the upper creases at the very top of her legs and also under her breasts; which will sometimes get red; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash), PRURITUS (Arm itchy/not as itchy as after her first dose), PARAESTHESIA (feel a slight tingling in the upper creases at the very top of her legs and also under her breasts) and ERYTHEMA (which will sometimes get red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 004M20A) for COVID-19 vaccination.     No Medical History Reported.  Concomitant products included LOSARTAN for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash), PRURITUS (Arm itchy/not as itchy as after her first dose), PARAESTHESIA (feel a slight tingling in the upper creases at the very top of her legs and also under her breasts) and ERYTHEMA (which will sometimes get red). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash) and PRURITUS (Arm itchy/not as itchy as after her first dose) had not resolved and PARAESTHESIA (feel a slight tingling in the upper creases at the very top of her legs and also under her breasts) and ERYTHEMA (which will sometimes get red) outcome was unknown. Not Provided          With the second one she took a zyrtec an hour before receiving the vaccine. Treatment medications included Cortisone.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up added on 10-May-2021: Events added. Reporter details and contact info updated. On 26-May-2021: Follow up on 26-May-2021: Included no new information
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neck pain, Swelling
Clinical narrative: pain and stiffness in neck; Swelling of wrist and hand; pain and stiffness in neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain and stiffness in neck), MUSCULOSKELETAL STIFFNESS (pain and stiffness in neck) and SWELLING (Swelling of wrist and hand) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Drug allergy. Concomitant products included BIFIDOBACTERIUM LACTIS (PROBIOTIC [BIFIDOBACTERIUM LACTIS]) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced NECK PAIN (pain and stiffness in neck). On 23-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (pain and stiffness in neck) and SWELLING (Swelling of wrist and hand). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, NECK PAIN (pain and stiffness in neck), MUSCULOSKELETAL STIFFNESS (pain and stiffness in neck) and SWELLING (Swelling of wrist and hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included ibuprofen. She had her first dose of vaccine on March 13th 2021. It was given on left arm. Caller mentioned that on 22nd March she had stiffness and pain in neck. On 23rd Night she noticed swelling in wrists and hands. She has taken Ibuprofen for this. Caller asked about the ingredients of the vaccine, she wanted to know if vaccine contains Acyclovir as she is allergic to that medication.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash
Clinical narrative: Rashes over left side of trunk extending to her lower back; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rashes over left side of trunk extending to her lower back) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced RASH (Rashes over left side of trunk extending to her lower back) and HEADACHE (headache). At the time of the report, RASH (Rashes over left side of trunk extending to her lower back) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Pain in jaw, Toothache
Clinical narrative: Severe jaw pain; Pain brushing her teeth; Right side of her face hurt; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN JAW (Severe jaw pain), TOOTHACHE (Pain brushing her teeth) and FACIAL PAIN (Right side of her face hurt) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN JAW (Severe jaw pain), TOOTHACHE (Pain brushing her teeth) and FACIAL PAIN (Right side of her face hurt). On 08-Mar-2021, PAIN IN JAW (Severe jaw pain), TOOTHACHE (Pain brushing her teeth) and FACIAL PAIN (Right side of her face hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for Covid; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for Covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    .
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Diarrhoea, Dizziness
Clinical narrative: dizziness; weak; diarrhea; no appetite; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (weak), DIARRHOEA (diarrhea) and DECREASED APPETITE (no appetite) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced DIZZINESS (dizziness), ASTHENIA (weak), DIARRHOEA (diarrhea) and DECREASED APPETITE (no appetite). The patient was treated with ACETAMINOPHEN for Symptomatic treatment, at an unspecified dose and frequency and NAPROXEN ongoing from 22-May-2021 for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness), ASTHENIA (weak), DIARRHOEA (diarrhea) and DECREASED APPETITE (no appetite) outcome was unknown. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Mild redness at the site of the injection on left arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (Mild redness at the site of the injection on left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Mild redness at the site of the injection on left arm). At the time of the report, VACCINATION SITE ERYTHEMA (Mild redness at the site of the injection on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 antibody test negative
Clinical narrative: waiting 2 weeks from 2nd vaccine and had a negative antibody test; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (waiting 2 weeks from 2nd vaccine and had a negative antibody test) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 026A21A) for COVID-19 vaccination.  The patient's past medical history included Lymphoma. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for Antibiotic therapy, OBINUTUZUMAB for Lymphoma.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (waiting 2 weeks from 2nd vaccine and had a negative antibody test). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (waiting 2 weeks from 2nd vaccine and had a negative antibody test) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: unknown Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Headache, Nasopharyngitis, Pain in extremity
Clinical narrative: Shaking rigors, similar to grand mal seizure / Continuous shaking; Very cold; Sore arm; Got really hot; Chills / Rigors coming in waves; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Mar-2021 and was forwarded to Moderna on 24-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking rigors, similar to grand mal seizure / Continuous shaking), NASOPHARYNGITIS (Very cold), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Got really hot) and CHILLS (Chills / Rigors coming in waves) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced TREMOR (Shaking rigors, similar to grand mal seizure / Continuous shaking), NASOPHARYNGITIS (Very cold), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Got really hot), CHILLS (Chills / Rigors coming in waves) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, TREMOR (Shaking rigors, similar to grand mal seizure / Continuous shaking), NASOPHARYNGITIS (Very cold), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Got really hot), CHILLS (Chills / Rigors coming in waves) and HEADACHE (Headache) outcome was unknown.            No concomitant medications were reported.  Treatment information included pre-medicated with Tylenol and Benadryl two hours prior to vaccine and took again 6 hours after the vaccine. Took another Benadryl at 10 pm.   This case was linked to MOD-2021-056016 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Dosing details were updated.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Shaking rigors, similar to grand mal seizure / Continuous shaking; Very cold; Sore arm; Got really hot; Chills / Rigors coming in waves; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Mar-2021 and was forwarded to Moderna on 24-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking rigors, similar to grand mal seizure / Continuous shaking), NASOPHARYNGITIS (Very cold), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Got really hot) and CHILLS (Chills / Rigors coming in waves) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced TREMOR (Shaking rigors, similar to grand mal seizure / Continuous shaking), NASOPHARYNGITIS (Very cold), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Got really hot), CHILLS (Chills / Rigors coming in waves) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, TREMOR (Shaking rigors, similar to grand mal seizure / Continuous shaking), NASOPHARYNGITIS (Very cold), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Got really hot), CHILLS (Chills / Rigors coming in waves) and HEADACHE (Headache) outcome was unknown.            No concomitant medications were reported.  Treatment information included pre-medicated with Tylenol and Benadryl two hours prior to vaccine and took again 6 hours after the vaccine. Took another Benadryl at 10 pm.   This case was linked to MOD-2021-056016 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Dosing details were updated.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site hypoaesthesia
Clinical narrative: Numbness in the arm of the injection; Both of my legs and feet; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HYPOAESTHESIA (Numbness in the arm of the injection) and HYPOAESTHESIA (Both of my legs and feet) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced INJECTION SITE HYPOAESTHESIA (Numbness in the arm of the injection) and HYPOAESTHESIA (Both of my legs and feet). At the time of the report, INJECTION SITE HYPOAESTHESIA (Numbness in the arm of the injection) and HYPOAESTHESIA (Both of my legs and feet) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Pain in extremity, Paraesthesia
Clinical narrative: cold on left side of her face; tingling sensation on left side of her face; soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness of arm), FEELING COLD (cold on left side of her face) and PARAESTHESIA (tingling sensation on left side of her face) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00A3217) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness of arm). On 24-Mar-2021, the patient experienced FEELING COLD (cold on left side of her face) and PARAESTHESIA (tingling sensation on left side of her face). The patient was treated with IBUPROFEN ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness of arm), FEELING COLD (cold on left side of her face) and PARAESTHESIA (tingling sensation on left side of her face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: inadvertently administered the 2 doses of the vaccine to a 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered the 2 doses of the vaccine to a 17 year old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036b21a and 013a21a) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered the 2 doses of the vaccine to a 17 year old). On 22-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inadvertently administered the 2 doses of the vaccine to a 17 year old) had resolved.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment medications were not provided by the reporter. Action taken with mRNA-1273 in response to the events were not Applicable. The patient received both the doses with no adverse event.   This case was linked to MOD-2021-225150 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-Jun-2021 describes about second dose , race information and ethnic group.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number 013A21A) with no associated AEs reported.